Thermo Fisher Scientific Inc (TMO) support and resistance · P/E 24, rev $44.56B
Thermo Fisher Scientific Inc (TMO) is a diagnostics & research company listed on US.
This page maps Thermo Fisher Scientific Inc (TMO) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported TMO revenue for 2025-12-31 was $44.56B. Net income was $6.70B. Revenue was up 3.9% from 2024-12-31 to 2025-12-31. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
TMO currently screens at market cap $153.06B and trailing P/E 23.8. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new TMO 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the TMO quote page for the session range and the stock page for the full model.
Not investment advice.